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Effects of Dietary Salt Restriction on Puromycin 
Aminonu  cleoside Nephrosis: Preliminary Data
Original article
Proteinuria is a major promoter that induces tubulointerstitial injury in glomerulo­
pathy. Dietary salt restriction may reduce proteinuria, although the mechanism 
is not clear. We investigated the effects of dietary salt restriction on rat kidneys 
in an animal model of glomerular proteinuria. Male Sprague­Dawley rats were 
used and divided into 3 groups: vehicle­treated normal­salt controls, puromycin 
aminonucleoside (PA)­treated normal­salt rats, and PA­treated low­salt rats. 
PA was given at a dose of 150 mg/kg BW at time 0, followed by 50 mg/kg 
BW on days 28, 35, and 42. Sodium­deficient rodent diet with and without 
additional NaCl (0.5%) were provided for normal­salt rats and low­salt rats, 
respectively. On day 63, kidneys were harvested for histopathologic examination 
and immunohistochemistry. PA treatment produced overt proteinuria and renal 
damage. Dietary salt restriction insignificantly reduced proteinuria in PA­treated 
rats, and PA­treated low­salt rats had lower urine output and lower creatinine 
clearance than vehicle­treated normal­salt controls. When tubulointerstitial injury 
was semiquantitatively evaluated, it had a positive correlation with proteinuria. 
The tubulointerstitial injury score was significantly increased by PA treatment 
and relieved by low­salt diet. ED1­positive infiltrating cells and immunostaining 
for interstitial collagen III were significantly increased by PA treatment. These 
changes appeared to be less common in PA­treated low­salt rats, although the 
differences in PA­treated normal­salt versus low­salt rats did not reach statistical 
significance. Our results suggest that renal histopathology in PA nephrosis may 
potentially be improved by dietary salt restriction. Non­hemodynamic mechanisms 
induced by low­sodium diet might contribute to renoprotection.
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1-3). 
Glomerular proteinuria is a risk factor for both progression 
of chronic renal failure and interstitial fibrosis, suggesting a 
causative relationship between glomerular protein ultrafilt-
ration and interstitial fibrogenesis. Thus, proteinuria or 
albuminuria is not only just a marker for the glomerular 
ultrafiltration, but also an important mediator for tubular 
Introduction
In glomerular disease, variable degrees of tubulointerstitial 
injury and fibrosis coexist. The tubulointerstitial fibrosis is 
prominent in glomerular diseases that progress to chronic 
renal failure, and the glomerular filtration rate correlates 
better with tubulointerstitial injury than with glomerular 
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actions of ultrafiltered, biologically active growth factors 
which stimulate tubular cells causing basolateral secretion of 
chemokines and cytokines. Chemokines attract and activate 
macrophages. Tubular cell-derived platelet-derived growth 
factor (PDGF) and macrophage-derived transforming 
growth factor-β (TGF-β) cause fibroblast proliferation. 
Several growth factors contribute to their transition into 
extracellular matrix-producing myofibroblasts
4). 
High sodium intake increases blood pressure and pro-
teinuria, induces glomerular hyperfiltration and blunts 
the response to renin–angiotensin–aldosterone system 
(RAAS) blockade
5). Besides, dietary salt intake may have a 
role in modulating intrarenal production of TGF-β
6-8). The 
mechanism is independent of angiotensin II and sys  temic 
blood pressure and involves activation of vascular endo-
thelium by dietary salt intake with release of this growth 
factor
9). It is now clear that TGF-β has a potent role in 
chronic progression of renal disease
10), and that Smad3 is 
critical for TGF-β's pro-fibrotic effect
11).
On the other hand, the effects of low sodium intake on 
renal progression are not clear. It is conceivable that strict 
restriction of dietary salt intake activates RAAS, precipi-
tating renal progression. This study was undertaken to test 
if dietary salt restriction may modulate glomerular protein-
uria-induced tubulointerstitial damage using a rat model of 
puromycin aminonucleoside nephrosis.
Materials and Methods
1. Animal experiment
Specific pathogen-free male Sprague-Dawley rats (Orient 
Bio Inc., Seongnam, Korea) weighing 120–150 g, were used 
for induction of puromycin aminonuceloside nephrosis. Rats 
were divided into 3 groups: vehicle-treated normal-salt 
controls (n = 3), puromycin aminonucleoside (PA)-treated 
normal-salt rats (n = 3), and PA-treated low-salt rats (n = 
3). PA (Sigma, St. Louis, MO, USA) was dissolved in 0.9% 
saline (vehicle) and used at a concentration of 10 mg/mL. 
On day 0, PA-treated rats were given an intraperitoneal 
injection of PA 150 mg/kg BW, and vehicle-treated normal-
salt controls were given an intraperitoneal injection of the 
same volume of 0.9% saline. Second, third and fourth doses of 
PAN (50 mg/kg BW i.p.) were administered to the PA-treated 
rats at 4, 5 and 6 weeks after the initial dose; the control rats 
received i.p. saline at the same times. 
All rats were maintained on a food slurry, a mixture of 
base diet (18 g/200 g BW) and deionized water (9 mL/200 g 
BW). The base diet was a commercially available synthetic 
rat chow containing no added NaCl (DYET #113763 Sodium 
Deficient AIN-93G Purified Rodent Diet, Dyets Inc., Bethle-
hem, PA, USA) and offered for low-salt rats. Normal-salt 
rats were fed the base diet containing added NaCl (0.5%). 
Furthermore, drinking water was freely accessible to all rats. 
Animals were housed individually in metabolic cages to 
provide a daily fixed amount of food and to obtain 24-hour 
collections of urine. The animal experiment was terminated 
on day 63, and kidneys were harvested for histopathologic 
examination and immunohistochemistry. The experimental 
protocol was approved by the institutional Animal Care and 
Use Committee of Hanyang University. 
2. Histopathology
Renal tissues were fixed in 10% neutral-buffered formalin 
and were embedded in paraffin. Four-micron paraffin sec  tions 
were stained with hematoxylin and periodic acid-Schiff (PAS) 
or with Masson’s trichrome. Tubulointerstitial injury was 
scored semiquantitatively on PAS-stained tis  sues, with a 20X 
objective, as described previously
12). Tubulointer  stitial injury 
was defined as tubular dilation, tubular atrophy, sloughing of 
tubular epithelial cells, or thickening of the tubular basement 
membrane and was scored on a scale of 0 to 4, as follows: 0, 
no tubulointerstitial injury; 1, < 25% of the tubulointerstitium 
injured; 2, 25 to 50% of the tubulointerstitium injured; 3, 
51 to 75% of the tubulointerstitium injured; 4, > 75% of the 
tubulointerstitium injured. 
The extent of tubulointerstitial scarring was evaluated on 
trichrome-stained sections to assess the relative proportion 
of interstitial fibrosis. For each animal, 15 photographs of 
random areas of cortex and medulla are taken at 100X mag-Electrolyte Blood Press 9:55­62, 2011 • doi: 10.5049/EBP.2011.9.2.55    57
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nification; the photographs are converted to JPEG files using 
a scanner, at a resolution of 200 pixels/inch. The relative 
fraction of red and blue pixels in each image was quantified 
using SigmaScan software
13).
3. Immunohistochemistry
The kidneys were preserved by retrograde per  fusion via 
the abdominal aorta with 1% phosphate-buffered saline 
(PBS) to remove blood and then with periodate-lysine-
paraformaldehyde (PLP; 0.01 M NaIO4, 0.075 M lysine, 
2% paraformaldehyde, in 0.0375 M Na2HPO4 buffer, pH 
6.2) for kidney fixation for 3 minutes. After completion of 
perfusion, each kidney was sliced into 5 mm thick sections 
and immersed in 2% PLP solution overnight at 4℃. 
Immunohistochemical staining for osteopontin (OPN) 
protein and macrophage accumulation was performed 
on formalin-fixed, paraffin-embedded sections using a 
microwave antigen retrieval method
14). Sections were depa-
raffined with a graded series of ethanol, and treated with 
14 minutes of microwave oven heating in 0.01 mM sodium 
citrate, pH 6.0, at 2,450 MHz and 800W. Endo  genous 
peroxidase was inactivated by incubation in 3% H2O2 in 
methanol. After preincubation with 10% normal goat serum 
(S-1000; Vector Laboratory, Burlington, CA) for 1 hour, 
sections were incubated overnight at 4℃ with mouse mAbs 
to rat OPN (MPIIIB10; obtained from the De  velopmental 
Studies Hybridoma Bank, Iowa City, IA, USA) or rat ma-
crophages (ED1, Serotec, Oxford, UK). For ED1 IHC, 
pretreatment with trypsin (Sigma) was done at 37℃ for 15 
minutes. They were washed with PBS and incubated for 2 
hours with a DAKO Envision kit (DAKO, Glostrup, Den-
mark) at room temperature. Sections then were washed in 
0.05M Tris buffer, and developed with a mixture of 3,3’- 
diaminobenzidine and 0.033% H2O2 in Tris buffer. They 
were were counter-stained with hematoxylin, and slides 
were mounted with Canadian balasam (Sigma, St. Louis, 
MO, USA).
OPN protein expression was assessed quantitatively by 
measuring the area of immunostaining for OPN using a com-
puterized image analyzer (Leica Application Suite; Leica Micro-
systems, Wetzlar, Germany). This was performed by assessing all 
fields under a 20X objective encountered in tracing a serpentine 
course in a section of kidney
15). A point-counting technique 
was used to quantitate the number of interstitial ED1-positive 
cells. Interstitial ED1-positive macrophages were counted in at 
least 20 consecutive high-power fields
14).
4. Statistics
Values are presented as means ± SE. Comparisons between 
groups were performed by the Mann-Whitney U-test. 
Correlations between variables of interest were analyzed by 
linear regression. P values of less than 0.05 were considered 
statistically significant. 
Results 
1. Plasma and urine data
At the end of the animal experiment, there were no diffe-
rences in body weight between the groups: vehicle-treated 
normal-salt controls, 332 ± 1 g; PA-treated normal-salt 
rats, 297 ± 13 g; and PA-treated low-salt rats, 312 ± 7 g. 
The 3 groups also had no differences in weight gain over 
the study period. 
Urine and plasma data obtained on the final day of the 
animal experiment are shown in Table 1. Urine volume 
was not significantly affected by PA administration, but PA-
treated low-salt rats had smaller urine output than vehicle-
treated normal-salt controls (5.0 ± 1.2 versus 14.7 ± 3.8 
mL/day, P < 0.05). However, there were no differences 
in urine osmolality between the groups. As expected, PA-
treated low-salt rats had smaller urinary excretions of 
sodium and chloride. Interestingly, urinary potassium 
excretion was significantly decreased by PA administration, 
irrespective of dietary salt restriction. However, plasma 
sodium, potassium and chloride concentrations showed no 
differences between the groups.
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teinuria was increased in PA-treated normal-salt rats (5.1 ± 
0.5 versus 98.7 ± 59.8 mg/day, P < 0.05). Although the mean 
value of proteinuria in PA-treated low-salt rats (20.5 ± 6.0 
mg/day) was lower than in PA-treated normal-salt rats, the 
difference did not reach statistical significance. Interestingly, 
the plasma albumin level was significantly increased in PA-
treated low-salt rats compared with vehicle-treated normal-
salt controls (3.6 ± 0.7 versus 3.1 ± 0.3 g/dL, P < 0.05). 
Al  though blood urea nitrogen and plasma creatinine were not 
different between the groups, creatinine clearance was signi-
ficantly lowered in PA-treated low-salt rats compared with 
vehicle-treated normal-salt controls (0.6 ± 0.2 versus 1.3 ± 
0.1 mL/min, P < 0.05). 
2. Renal tissue examination
Nine weeks after 4 times’ PA administration, overt tubu-
lointerstitial abnormalities were noted in the kidney. They 
included interstitial edema and inflammatory cell infiltra-
tion, tubular atrophy and dilatation, and intratubular casts 
with intraluminal cellular debris. When these were semi-
quantitatively evaluated, the results were: vehicle-treated 
normal-salt controls, 0.2 ± 0.0; PA-treated normal-salt rats, 
3.2 ± 0.4; and PA-treated low-salt rats, 1.7 ± 0.2. There 
were significant differences in tubulointerstitial injury score 
bet  ween the groups, and PA-treated low-salt rat kidneys 
showed significantly (P < 0.05) less tubulointerstitial 
injury than PA-treated normal-salt rats (Fig. 1). In contrast, 
glomeruli showed only minor changes such as mild 
hypercellularity in PA-treated rat kidneys.
The relationship between proteinuria and tubulointer-
stitial injury was demonstrated in Figure 2. The degree of 
proteinuria correlates positively with that of tubulointerstitial 
injury (r=0.76, P < 0.05). 
Figure 3 shows ED1 immunohistochemistry illustrative 
of macrophage infiltration. PA treatment induced a remark-
able increase in the number of ED1-positive cells in the 
kidney (345 ± 136 versus 2,106 ± 415/HPF, P < 0.05). 
With dietary salt restriction, the increased macrophage 
infiltration was insignificantly reversed (1,214 ± 268/HPF). 
Figure 4 shows OPN immunohistochemistry from vehicle- 
treated normal-salt controls, PA-treated normal-salt rats, 
and PA-treated low-salt rats. When the area of immunos-
taining for OPN was quantitatively assessed, the results 
Table 1. Urine and Plasma Data 
Vehicle-NS (n = 3) PA-NS (n = 3) PA-LS (n = 3)
Urine 
  Volume (mL/day) 14.7 ± 3.8 8.3 ± 2.2 5.0 ± 1.2*
  Osmolality (mOsm/kg H2O) 900 ± 211 1272 ± 438 1136 ± 111
  Sodium (µmol/day) 958 ± 140 729 ± 169 231 ± 81
†*
  Potassium (µmol/day) 1110 ± 172 751 ± 29* 595 ± 74
†*
  Chloride (µmol/day) 1193 ± 205 943 ± 135 408 ± 104
†*
  Protein (mg/day) 5.1 ± 0.5 98.7 ± 59.8* 20.5 ± 6.0 *
Plasma
  Sodium (mEq/L) 148 ± 1 150 ± 0 150 ± 0
  Potassium (mEq/L) 3.9 ± 0.1 4.1 ± 0.2 3.6 ± 0.3
  Chloride (mEq/L) 106 ± 1 106 ± 2 104 ± 1
  Protein (g/dL) 6.0 ± 0.1 6.2 ± 0.2 6.4 ± 0.2
  Albumin (g/dL) 3.1 ± 0.3 3.2 ± 0.2 3.6 ± 0.7*
  Urea nitrogen (mg/dL) 17.9 ± 2.0 17.9 ± 2.1 20.7 ± 3.1
  Creatinine (mg/dL) 0.7 ± 0.1 0.6 ± 0.1 0.7 ± 0.1
Creatinine clearance (mL/min) 1.3 ± 0.1 0.9 ± 0.2 0.6 ± 0.2*
 Data are mean±SE. Comparisons were performed by Mann-Whitney U test. NS, normal-salt diet; PA, puromycin aminonucleoside; LS, low-salt diet.
*P < 0.05 versus Vehicle-NS. 
†P < 0.05 versus PA-NS. Electrolyte Blood Press 9:55­62, 2011 • doi: 10.5049/EBP.2011.9.2.55    59
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were: vehicle-treated normal-salt controls, 0.12 ± 0.11 %area; 
PA-treated normal-salt rats, 0.51 ± 0.32%area; and PA-
treated low-salt rats, 0.13 ± 0.07%area. Thus the renal ex  pres-
sion of OPN seemed to be increased by PA treatment and 
relieved by low-salt diet. However, these changes were not 
statistically significant.
The interstitial accumulation of collagen III was signifi-
cantly increased in PA-treated normal-salt rat kidneys com-
pared with vehicle-treated normal-salt controls (3.12 ± 0.89 
versus 0.81 ± 0.26 %area, P < 0.05). As compared with 
PA-treated normal-salt rats, PA-treated low-salt rat kidneys 
showed a decreasing tendency in interstitial collagen III 
immunostaining (1.67 ± 0.57 %area, Fig. 5) However, 
the difference was not statistically significant. When we 
examined blue-to-red pixel ratios on Masson’s trichrome 
staining (Fig. 6), the results were: vehicle-treated normal-
salt controls, 0.187 ± 0.053; PA-treated normal-salt rats, 0.252 
± 0.004; and PA-treated low-salt rats, 0.183 ± 0.053. 
There were no significant differences between the groups.
Discussion
This preliminary study was designed to test whether low-
Fig. 1
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Cortex
Medulla
Fig. 1. Histopathology of the Kidney Using Periodic Acid­Schiff (PAS) 
Staining. Representative sections are shown from each group (A), and 
results of semiquantitative evaluation of tubulointerstitial injury are 
summarized in a bar graph (B). Magnification X200. PA, puromycin ami­
nonucleoside; NS, normal­salt diet; LS, low­salt diet. 
*P < 0.05 versus Vehicle­NS.
†P < 0.05 versus PA­NS. 
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r = 0.76, P < 0.05 
Fig. 2. Correlation between Proteinuria and Tubulointerstitial Injury Score. 
Tubulointerstitial injury correlates positively with proteinuria in this animal 
experiment.
Fig. 3
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Fig. 3. Immunohistochemistry for ED1 in Rat Kidneys. Representative 
sections are shown from each group (A), and results of quantitative 
evaluation of immunostaining are summarized in a bar graph (B). Magni­
fication X200. PA, puromycin aminonucleoside; NS, normal­salt diet; 
LS, low­salt diet. 
*P < 0.05 versus Vehicle­NS. 60      Jo CH et al. • Effects of Dietary Salt Restriction on Puromycin Aminonucleoside Nephrosis: Preliminary Data
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sodium diet is beneficial to glomerular proteinuria-induced 
tubulointerstitial injury. To produce nephrotic syndrome, we 
used the animal model of chronic purine aminonucleoside 
nephrosis (PAN)
16). With dietary salt restriction, PAN rats had 
insignificant reduction of proteinuria but showed significant 
improvement in tubulointerstitial injury in their kidneys. 
Restriction of dietary sodium may reduce proteinuria 
probably via renal hemodynamic alteration
5). In white salt-
sensitive hypertensive patients, high sodium intake (250 
mmol/day) was associated with an almost 35% increase 
in albuminuria as compared with low sodium intake (20 
mmol/day)
17). The antiproteinuric effect in black (mostly 
salt sensitive) hypertensive patients was 19% when re  ducing 
dietary sodium intake
18). In IgA nephropathy, reduction of 
dietary sodium from 12 to 5 g/day reduced proteinuria by 
approximately 30–50%
19), and in patients with nondiabetic 
proteinuria, dietary sodium restriction (urinary sodium 
excretion from 200 to 90 mmol/24 hr) reduced proteinuria 
from 3.9 to 2.7 g/24 hr
20). In these studies on hypertensive 
kidney disease, the reduction in proteinuria during low 
sodium intake was generally but not invariably associated 
with a lower blood pressure. In healthy individuals, on 
the contrary, reduction of dietary sodium from 200 to 
50 mmol/24 hr significantly reduced urinary albumin 
excretion within the normal range, independent of BP, in-
dicating specific renoprotective effects of dietary sodium 
restriction
21-23). This is in line with the BP-independent 
association between urinary sodium excretion and albumi-
nuria in the general population
24). Regarding animal data, 
we could find no reports on dietary salt restriction in PAN 
rats.
We investigated non-hemodynamic renal mechanisms 
by which dietary salt restriction exerts renoprotection. The 
association between proteinuria and progression of chronic 
kidney disease is firmly established, and in this study we 
showed a correlation between proteinuria and tubulointerstitial 
injury. Tubular cells exposed to high concentration of 
proteins produce proinflammatory and profibrotic factors
25). 
Fig. 4
A
B
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Cortex
Medulla
Fig. 4. Immunohistochemistry for Osteopontin in Rat Kidneys. Repre­
sentative sections are shown from each group (A), and results of quantitative 
evaluation of immunostaining are summarized in a bar graph (B). No 
significant differences were noted between groups. Magnification X200. 
PA, puromycin aminonucleoside; NS, normal­salt diet; LS, low­salt diet. 
Fig. 5
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Fig. 5. Immunohistochemistry for Collagen III in Rat Kidneys. Representa­
tive sections are shown from each group (A), and results of quantitative 
evaluation of immunostaining are summarized in a bar graph (B). Magni­
fication X200. PA, puromycin aminonucleoside; NS, normal­salt diet; LS, 
low­salt diet.
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As biomarkers for this connection between glomerular 
proteinuria and tubulointerstitial inflammation, we examined 
the inflammatory cell infiltra  tion and OPN expression in the 
tubulointerstitium. Pre  viously, increased expression of OPN 
associated with in  terstitial monocyte infiltration has been 
demonstrated in chronic PAN rat kidneys
15). We also showed 
increased tubular OPN expression and interstitial ED1-
positive cell infiltration in PAN rats. These changes appeared 
less in PA-treated low-salt rats although the differences in PA-
treated normal-salt versus low-salt rats did not reach statistical 
significance.
TGF-β is the most important molecule to activate the 
fibrogenic cascades in the process of tubulointerstitial injury. 
High sodium intake increases renal expression of TGF-β
6, 
26). However, the effect of low sodium diet compared with 
normal sodium intake is not clear. We tested if the TGF-β/
Smad3 signaling pathway was affected in our animals, but 
no significant changes were found (data not shown). 
We examined interstitial fibrosis by collagen III immu-
nohistochemistry and Masson’s trichrome staining. As 
expected, the interstitial accumulation of collagen III was 
significantly increased by PA treatment. This increase in 
collagen III expression seemed to be relieved by dietary 
salt restriction although the difference was not statistically 
significant. We believe that we obtained insignificant 
changes in the number of ED1-positive cells and immuno-
staining for OPN and collagen III between the groups 
because of the small number of animals used in this study. 
Further studies are required to resolve these issues. 
On the other hand, we are concerned if too little salt 
intake might have negative consequences. Radical salt res-
triction causes hypovolemia, with the attendant adverse ef-
fects
27). In this study, urine output and creatinine clearance 
tended to be lower in both PA-treated normal-salt rats and 
PA-treated low-salt rats. However, the change from vehicle-
treated normal-salt controls was larger in PA-treated low-
salt rats, and the differences in PA-treated low-salt rats only 
reached statistical significance. Thus, it is not clear whether 
the long-term renal outcome would be improved by low salt 
intake in glomerulopathy. Whereas dietary salt restriction 
may relieve glomerular hyperfiltration, it may up-regulate 
the activity of the renin–angiotensin system, increases 
angiotensin II, and up-regulate NADPH oxidase, thus, 
generating reactive oxidant species
28). In both humans and 
animals, the optimal dietary salt deprivation needs to be 
elucidated for benefits versus risks. 
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